Clinical Trials for Lymphoma

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

NCT ID: NCT03934372

This clinical trial is studying a medication called ponatinib to see how safe and effective it is for treating children and young adults aged 1 to 17 years who have advanced types of leukemia, lymp...

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

NCT ID: NCT04637763

The ANTLER clinical trial is studying a new treatment called CB010A for adults with a type of blood cancer known as relapsed or refractory B-cell non-Hodgkin lymphoma. This means the lymphoma has e...

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

NCT ID: NCT05663502

This clinical trial is focused on collecting blood and tissue samples from individuals to help researchers better understand cancers related to HIV (human immunodeficiency virus) and AIDS (acquired...

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

NCT ID: NCT03696784

This clinical trial is investigating a new treatment for patients with certain types of B-cell lymphoma, which is a cancer affecting the immune system. The treatment combines two approaches: modify...

Hypofractionation Radiotherapy in Combination with Glofitamab in Relapsed/refractory Diffuse B-cell Lymphoma with Baseline High Tumor Burden

NCT ID: NCT06867536

This clinical trial is studying a new treatment approach for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), particularly those who have a high tumor burden. The trial c...

Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy

NCT ID: NCT01382082

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma

NCT ID: NCT04739813

This clinical trial, called ViPOR-P, is exploring a new combination of medications to help adults with certain types of B-cell lymphoma, which is a kind of blood cancer. Specifically, the researche...

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

NCT ID: NCT03602157

This clinical trial is studying a new type of treatment for certain types of lymphoma, which is a cancer of the immune system. The treatment involves using specially modified T cells (a type of whi...

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

NCT ID: NCT04977024

This clinical trial is studying a new vaccine called GEO-CM04S1 to see how well it helps people with blood cancers, like leukemia and lymphoma, build immunity against COVID-19. The trial compares t...

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients with Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

NCT ID: NCT06859424

This clinical trial is studying the best way to prevent a condition called graft-versus-host disease (GVHD) in patients who receive stem cell transplants from unrelated donors. GVHD occurs when the...

First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228

NCT ID: NCT05737628

This clinical trial is testing a new treatment called BYON4228, which is a type of medicine known as a monoclonal antibody. This trial is specifically for patients with certain types of lymphoma, a...

A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma

NCT ID: NCT06563505

This clinical trial is testing a new combination of two medications, mosunetuzumab and zanubrutinib, to see how effective and safe they are for patients with relapsed or refractory marginal zone ly...

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

NCT ID: NCT04898790

This clinical trial is studying how physical activity can help improve thinking and memory skills in older adults who have recently undergone a stem cell transplant for blood cancers like leukemia ...

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

NCT ID: NCT06860880

This clinical trial, titled "Combating Cancer-Related Fatigue: A Personalized Supportive Care Program," is designed to help patients with certain types of indolent lymphomas, including chronic lymp...

Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults with Cancer

NCT ID: NCT05858424

This clinical trial is studying how a special program called a multidisciplinary end-of-treatment day hospital can help improve the quality of life for adolescents and young adults who have recentl...

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

NCT ID: NCT06698003

This clinical trial is investigating a medication called mogamulizumab to see if it can help prevent adult T-cell leukemia/lymphoma (ATL) in individuals who are at higher risk due to being infected...

Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis

NCT ID: NCT05388838

This clinical trial is looking at a new way to help diagnose a rare type of eye cancer called primary intraocular lymphoma (LIOP) in patients who have uveitis, which is an inflammation of the eye. ...

BRAZAN Trial in Frontline MCL

NCT ID: NCT06854003

The BRAZAN Trial is a clinical study designed to explore a new treatment approach for patients with Mantle Cell Lymphoma (MCL), a type of cancer affecting the lymphatic system. This trial will asse...

CD70-targeted immunoPET Imaging of Malignant Cancers

NCT ID: NCT06852638

This clinical trial is looking at a new imaging method called CD70-targeted immunoPET/CT, which aims to help doctors spot certain types of cancers, including renal cancer (specifically clear cell r...

Impact of an Early Warning System on the Prognosis of Patients with Hematological Malignancies Receiving Intensive Chemotherapy with or Without Hematopoietic Cell Transplantation.

NCT ID: NCT06409767

This clinical trial is studying how an early warning system can help improve the health outcomes of patients with blood cancers, such as leukemia, lymphoma, and multiple myeloma, who are receiving ...